Investor/Media Center

print page

Press Releases

 


Displaying releases: 1-40 | 41-80 | 81-120 | 121-160 | 161-200 | 201-207


Mar-19-2013 Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides
Mar-15-2013 PALATIN TECHNOLOGIES TO PRESENT AT THE 25TH ANNUAL ROTH CONFERENCE
Mar-04-2013 PALATIN TECHNOLOGIES, INC. TO PRESENT AT THE COWEN & COMPANY 33rd ANNUAL HEALTH CARE CONFERENCE
Mar-01-2013 Palatin Technologies Presents Positive Data for Bremelanotide in Female Sexual Dysfunction
Feb-14-2013 Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2013 Results; Teleconference and Webcast to be held on February 14, 2013
Feb-08-2013 Palatin Technologies, Inc. To Report Fiscal Year 2013 Second Quarter Results; Teleconference and Webcast to be held on February 14, 2013
Feb-07-2013 PALATIN TECHNOLOGIES, INC. TO PRESENT AT 15TH ANNUAL BIO CEO & INVESTOR CONFERENCE
Jan-03-2013 Palatin Technologies Receives $1.75 Million from Sale Of New Jersey State Tax Credits
Nov-21-2012 Palatin Technologies, Inc. to Present at the 24th Annual Piper Jaffray Healthcare Conference
Nov-14-2012 Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2013 Results; Teleconference and Webcast to be held on November 14, 2012
Nov-12-2012 Palatin Technologies, Inc. To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
Nov-09-2012 Palatin Technologies, Inc. To Report Fiscal Year 2013 First Quarter Results; Teleconference and Webcast to be held on November 14, 2012
Nov-08-2012 Palatin Technologies Reports Positive Results for Phase 2B Bremelanotide Female Sexual Dysfunction Trial
Sep-11-2012 Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2012 Results
Sep-10-2012 Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial
Sep-07-2012 Palatin Technologies Provides Update Regarding Its Obesity Research/Development Collaboration with AstraZeneca
Sep-06-2012 Palatin Technologies, Inc. To Report Fiscal Year 2012 Fourth Quarter Results; Teleconference and Webcast to be held on September 11, 2012
Jul-02-2012 Palatin Technologies, Inc. Announces Pricing of $35 Million Private Placement of Common Stock and Warrants
Jun-19-2012 Palatin Technologies Announces Halting of Phase I Clinical Trial of Obesity Compound in AstraZeneca Research Collaboration
May-14-2012 Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on May 14, 2012
May-08-2012 Palatin Technologies, Inc. To Report Fiscal Year 2012 Third Quarter Results; Teleconference and Webcast to be held on May 14, 2012
Apr-19-2012 Palatin Technologies Announces First Patient Dosed in Second Phase I Clinical Trial of Obesity Compound from Research Collaboration
Mar-08-2012 Palatin Technologies Completes Enrollment in Phase 2B Bremelanotide Female Sexual Dysfunction Trial
Mar-07-2012 PALATIN TECHNOLOGIES, INC. TO PRESENT AT THE 24th ANNUAL ROTH OC GROWTH STOCK CONFERENCE
Feb-15-2012 Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on February 15, 2012
Feb-09-2012 PALATIN TECHNOLOGIES TO PRESENT AT 14TH ANNUAL BIO CEO & INVESTOR CONFERENCE
Feb-08-2012 Palatin Technologies, Inc. To Report Fiscal Year 2012 Second Quarter Results; Teleconference and Webcast to be held on February 15, 2012
Jan-17-2012 Palatin Technologies Receives $1.1 Million from Sale Of New Jersey State Tax Credits
Jan-16-2012 Palatin Technologies to Present at BOCEMb, Noble Financial Capital Markets' Eighth Annual Equity Conference
Nov-30-2011 Palatin Technologies to Present at Windhover's Therapeutic Area Partnerships Conference
Nov-15-2011 Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
Nov-10-2011 Palatin Technologies, Inc. To Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
Oct-21-2011 PALATIN TECHNOLOGIES TO PRESENT AT 10TH ANNUAL BIO INVESTOR FORUM
Sep-22-2011 Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2011 Results
Sep-19-2011 Palatin Technologies, Inc. To Report Fiscal Year 2011 Fourth Quarter Results; Teleconference and Webcast to be held on September 22, 2011
Sep-09-2011 Palatin Technologies, Inc. to Present at the Rodman & Renshaw Annual Global Investment Conference
Aug-04-2011 Palatin announces commencement of a Phase 1 Trial for Obesity Compound in collaboration with AstraZeneca
Jun-28-2011 Palatin Technologies, Inc. Initiates Enrollment in Phase 2b Trial with Bremelanotide in Women with Female Sexual Dysfunction
Jun-23-2011 Alan Dunton, M.D., Joins Board of Directors of Palatin Technologies, Inc.
Jun-21-2011 Palatin Technologies, Inc. Issued U.S. Patent for Key Component in PL-3994 Drug Candidate